drugset / Trial / NCT02577588
Trial of Adoptive T Cell Therapy With Activated P53 Specific T Cells for Treatment of Advanced Colorectal Cancer
Phase 1
Terminated
1 enrolled
National Center for Tumor Diseases, Heidelberg
German Cancer Research Center · collabUniversity Hospital Heidelberg · collab
NaSingle-groupOpen-labelTreatment
Summary
The study "Phase I trial of Adoptive T cell Therapy with Activated P53 specific T cells for Treatment of Advanced Colorectal Cancer" is an open label, single arm trial.
Timeline
- Start
- 2016-05-01
- Primary completion
- 2018-02-19
- Completion
- 2018-02-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | therapeutic autologous lymphocytes | Cell therapy | 5e+07 cells | — |
| Subject | therapeutic autologous lymphocytes | Cell therapy | 5e+08 cells | — |